Variant position: 193 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 266 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human DVEAMARYVQDFHPRLLGLT GSTKQVAQASHSYRVYYNAGP
Mouse DVAAMARYVQEFHPRLLGLT GSTEQVAHASRNYRVYYSAGP
Bovine TVAAMARYVQDFHPRLLGLT GSAEQIAQVSRSYRVYYSAGP
Zebrafish DVSAMARYVKDFHPRLVGLT GSAEEVKQAGRDFRVYASNGP
Baker's yeast TPDVLKEYLSDFHPAIIGLT GTYDQVKSVCKKYKVYFST-P
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
42 – 266 Protein SCO2 homolog, mitochondrial
79 – 266 Mitochondrial intermembrane
85 – 259 Thioredoxin
A comprehensive genomic analysis reveals the genetic landscape of mitochondrial respiratory chain complex deficiencies.
Kohda M.; Tokuzawa Y.; Kishita Y.; Nyuzuki H.; Moriyama Y.; Mizuno Y.; Hirata T.; Yatsuka Y.; Yamashita-Sugahara Y.; Nakachi Y.; Kato H.; Okuda A.; Tamaru S.; Borna N.N.; Banshoya K.; Aigaki T.; Sato-Miyata Y.; Ohnuma K.; Suzuki T.; Nagao A.; Maehata H.; Matsuda F.; Higasa K.; Nagasaki M.; Yasuda J.; Yamamoto M.; Fushimi T.; Shimura M.; Kaiho-Ichimoto K.; Harashima H.; Yamazaki T.; Mori M.; Murayama K.; Ohtake A.; Okazaki Y.;
PLoS Genet. 12:E1005679-E1005679(2016)
Cited for: VARIANTS MC4DN2 SER-193 AND THR-258;
A novel homozygous SCO2 mutation, p.G193S, causing fatal infantile cardioencephalomyopathy.
Mobley B.C.; Enns G.M.; Wong L.J.; Vogel H.;
Clin. Neuropathol. 28:143-149(2009)
Cited for: VARIANT PRO-20; VARIANT MC4DN2 SER-193;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.